Stable preservative-free mydriatic and anti-inflammatory solutions for injection
AssigneeOmeros Corporation
InventorsGregory A. Demopulos, Hui-rong Shen, Clark E. Tedford
Life of this patent
Estimating the term…
Abstract
The present invention relates to stable, preservative- and antioxidant-free liquid formulations of phenylephrine and ketorolac for injection.
Claims16
A sterile liquid pharmaceutical formulation consisting essentially of phenylephrine, ketorolac and a buffer system in an aqueous carrier, wherein the formulation is stable for at least six months when stored at a temperature of from 5+/−3° C. to 25+/−2° C.
A sterile liquid pharmaceutical formulation comprising phenylephrine, ketorolac and a buffer system in an aqueous carrier, wherein the formulation is stable in the absence of preservatives and antioxidants for at least six months when stored at a temperature of from 5+/−3° C. to 25+/−2° C.
Dependencies are inferred from the claim text.